NDC 80425-0171-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0171
- Requested NDC
- 80425-0171-01
- Package NDCs from labels
- 80425-0171-3, 80425-0171-2, 80425-0171-1, 80425-0171-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0171-1 | Methocarbamol | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 8 | |
| 80425-0171-2 | Methocarbamol | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 8 | |
| 80425-0171-3 | Methocarbamol | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0171 | METHOCARBAMOL TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 8 | Current NDC, Legacy NDC, 3 package rows | 20250101_c9600cc9-7e27-6e19-e053-2995a90ab024.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0171-1 | EA - Each | 80425-0171 | cdc53f27-e0d3-4ffb-8af5-d419758d22bc | 1 | 2023-06-06 |
| 80425-0171-2 | EA - Each | 80425-0171 | 04ca45d9-2d21-4e99-8b9a-247d01ab4b7b | 1 | 2023-06-06 |
| 80425-0171-3 | EA - Each | 80425-0171 | afb9cb2e-d86c-48b1-bb44-f5928747d6fe | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ROBAXIN | METHOCARBAMOL | Hikma Pharmaceuticals USA Inc. | a418c43a-afe8-4a19-a57a-95c8dbe3d3d8 | 2024-04-10 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Medsource Pharmaceuticals | 127583d4-7963-bd6d-e063-6294a90ab73e | 2024-02-28 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Asclemed USA, Inc. | 1637e18d-d9f9-4171-99e6-4b866d821c87 | 2024-02-07 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | XLCare Pharmaceuticals Inc. | f8bfb5cb-b7d0-4e09-b6bd-97a51d82c991 | 2024-02-05 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 8cf27774-82ed-4ed1-a55d-41bf476745db | 2024-02-05 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Aurobindo Pharma Limited | f83dd093-ea53-44c1-a40d-682ebc494b62 | 2024-01-18 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | 2c1f5949-d771-45c6-8d8a-5e1942c853dc | 2024-01-05 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Asclemed USA, Inc. | 6155b45d-3ad3-4ca4-a6ee-42885414c0e1 | 2023-10-17 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Eugia US LLC | e8e8da30-64cf-42ea-bf71-d085b0be8a09 | 2023-10-13 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d8e3f8dc-9751-419b-8601-d85c43415c82 | 2023-09-21 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | f1bce76f-4c3a-40d2-8107-afc0d3a6ba19 | 2023-05-26 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 4003026f-ed9e-40ac-9e7e-5e28d32d7cb8 | 2023-05-26 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | b415184c-1603-4a86-92d2-746f8d3d3f3c | 2023-03-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d217bd1d-0b6e-4a4c-a47b-de73b94e8b13 | 2023-02-06 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Asclemed USA, Inc. | c40d5c1d-9bd8-44aa-85a4-e1a34e1d3673 | 2022-10-12 | Warnings, Adverse reactions | ANDA208507 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Proficient Rx LP | 10ae354f-94a4-4d4e-bccc-ea189726b7ce | 2022-10-01 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Proficient Rx LP | f6193255-0e83-4510-bc86-30c926ee8fd1 | 2022-04-01 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Proficient Rx LP | 201205d1-22f2-46bb-b298-02d4978ba568 | 2022-04-01 | Warnings, Adverse reactions | ANDA208507 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Aphena Pharma Solutions - Tennessee, LLC | 27c39343-44e0-4ca6-a67f-1e6d11dd6799 | 2021-11-10 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Camber Pharmaceuticals, Inc. | 43af0c41-9990-4902-9384-75de5ea08283 | 2021-04-06 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.